[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (296)

Search Parameters:
Keywords = nasal surgery

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
15 pages, 9787 KiB  
Article
Neoplasms in the Nasal Cavity Identified and Tracked with an Artificial Intelligence-Assisted Nasal Endoscopic Diagnostic System
by Xiayue Xu, Boxiang Yun, Yumin Zhao, Ling Jin, Yanning Zong, Guanzhen Yu, Chuanliang Zhao, Kai Fan, Xiaolin Zhang, Shiwang Tan, Zimu Zhang, Yan Wang, Qingli Li and Shaoqing Yu
Bioengineering 2025, 12(1), 10; https://doi.org/10.3390/bioengineering12010010 (registering DOI) - 25 Dec 2024
Abstract
Objective: We aim to construct an artificial intelligence (AI)-assisted nasal endoscopy diagnostic system capable of preliminary differentiation and identification of nasal neoplasia properties, as well as intraoperative tracking, providing an important basis for nasal endoscopic surgery. Methods: We retrospectively analyzed 1050 video data [...] Read more.
Objective: We aim to construct an artificial intelligence (AI)-assisted nasal endoscopy diagnostic system capable of preliminary differentiation and identification of nasal neoplasia properties, as well as intraoperative tracking, providing an important basis for nasal endoscopic surgery. Methods: We retrospectively analyzed 1050 video data of nasal endoscopic surgeries involving four types of nasal neoplasms. Using Deep Snake, U-Net, and Att-Res2-UNet, we developed a nasal neoplastic detection network based on endoscopic images. After deep learning, the optimal network was selected as the initialization model and trained to optimize the SiamMask online tracking algorithm. Results: The Att-Res2-UNet network demonstrated the highest accuracy and precision, with the most accurate recognition results. The overall accuracy of the model established by us achieved an overall accuracy similar to that of residents (0.9707 ± 0.00984), while slightly lower than that of rhinologists (0.9790 ± 0.00348). SiamMask’s segmentation range was consistent with rhinologists, with a 99% compliance rate and a neoplasm probability value ≥ 0.5. Conclusions: This study successfully established an AI-assisted nasal endoscopic diagnostic system that can preliminarily identify nasal neoplasms from endoscopic images and automatically track them in real time during surgery, enhancing the efficiency of endoscopic diagnosis and surgery. Full article
(This article belongs to the Special Issue New Sights of Deep Learning and Digital Model in Biomedicine)
Show Figures

Figure 1

Figure 1
<p>Workflow for analyzing endoscopic pictures by deep learning. Nasal endoscopic surgery videos were obtained. After pathological confirmation, representative images of five nasal neoplasms were marked. This was subsequently used to train the three networks: Deep Snake, U-Net, and Att-Res2-UNet. Each trained network was used to identify and analyze the lesions. It was then applied in the clinic to establish a diagnostic system for nasal endoscopy, and for tracing.</p>
Full article ">Figure 2
<p>Deep learning framework. (<b>A</b>) Network study workflow. (<b>B</b>) Identification and classification of the tissue in the nasal neoplasm region by the network confirming the lesion location. The outline of the nasal neoplasm was calculated from the heat map. NP: nasal Polyp; NIP: nasal inverted papilloma; FS: fungal sinusitis; NMT: nasal malignant tumor.</p>
Full article ">Figure 3
<p>Different appearances of the neoplasms in the nasal cavity in the endoscopic pictures and the heat map. (<b>A</b>) Three sets of endoscopic pictures and the heat map of nasal squamous cell carcinoma. (<b>B</b>) The endoscopic pictures and the heat map of nasal NK/T lymphoblastoma, the nasopharyngeal malignant tumor, and nasal adenocarcinoma. (<b>C</b>) The endoscopic pictures and the heat map of FS. (<b>D</b>) The endoscopic pictures and the heat map of NP. (<b>E</b>) The endoscopic pictures and the heat map of NIP. NP: nasal polyp; NIP: nasal inverted papilloma; FS: fungal sinusitis.</p>
Full article ">Figure 4
<p>Evaluation of the performance of Att-Res2-UNet network in identifying different lesion tissues in nasal cavities. (<b>A</b>) The ROC of Att-Res2-UNet for identifying NP, NIP, FS, and NMT. (<b>B</b>) Att-Res2-UNet identification of the NP, NIP, FS, and NMT confusion matrix. (<b>C</b>) Accuracy of different evaluation indicators (intersection and union ratio, dice coefficient, precision, and recall) for U-Net, Att-Res2-UNet, and Deep Snake. NP: nasal polyp; NIP: nasal inverted papillomas; FS: fungal sinusitis; NMT: nasal malignant tumors.</p>
Full article ">Figure 5
<p>Tracer flowchart and display. (<b>A</b>) Multi-scale feature fusion SiamMask tracking structure diagram. The diagram illustrates the main architecture of our proposed model. Blue arrows denote the feature encoding branch for video input, while green arrows indicate the feature encoding branch for prototypes. Black arrows represent the feature decoding branch. The operation *d signifies the matching between prototype features and video features, which is achieved by channel-wise multiplication to compute pixel-wise similarity, thereby enriching the semantic information of the video features relative to the prototypes. The decoder structure consists of deconvolutional layers (transposed convolutional layers) that progressively upsample the feature maps to higher resolutions, incorporating skip connections from the encoder to restore spatial information and enhance the precision of the segmentation output. (<b>B</b>) Video tracking display of endoscopic FS surgery. FS: fungal sinusitis.</p>
Full article ">
14 pages, 1681 KiB  
Article
Computed Tomography-Guided Radiofrequency Ablation of Nasal Carcinomas in Dogs
by María Dolores Alférez, Andrea Corda, Ignacio de Blas, Lucas Gago, Telmo Fernandes, Ignacio Rodríguez-Piza, Beatriz Balañá, Plamena Pentcheva, Javier Caruncho, Alicia Barbero-Fernández, Jorge Llinás, David Rivas, Amaia Escudero and Pablo Gómez-Ochoa
Animals 2024, 14(24), 3682; https://doi.org/10.3390/ani14243682 - 20 Dec 2024
Viewed by 250
Abstract
Nasal carcinomas in dogs are locally invasive neoplasms with a low metastatic rate that pose significant treatment challenges due to their location and aggressiveness. This study evaluates the safety, feasibility, and therapeutic outcomes of computed tomography-guided radiofrequency ablation (CT-guided RFA) in 15 dogs [...] Read more.
Nasal carcinomas in dogs are locally invasive neoplasms with a low metastatic rate that pose significant treatment challenges due to their location and aggressiveness. This study evaluates the safety, feasibility, and therapeutic outcomes of computed tomography-guided radiofrequency ablation (CT-guided RFA) in 15 dogs diagnosed with nasal adenocarcinoma. All patients underwent staging and histopathological diagnosis before treatment. CT-guided RFA achieved a significant tumor volume reduction (82.8%) and improvement in clinical signs such as nasal discharge, epistaxis, and respiratory distress, without complications. Post-RFA CT examinations demonstrated a significant decrease in Hounsfield units and tumor volume. This study has shown that CT-guided RFA is an effective cytoreductive option for minimally invasive management of nasal adenocarcinomas in dogs, particularly when traditional therapies like radiation therapy or surgery are not feasible. Full article
(This article belongs to the Section Veterinary Clinical Studies)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Closed polygon region of interest measured at T0 axial CT scan (<b>a</b>). CT scan from the same patient at T2 (<b>b</b>).</p>
Full article ">Figure 2
<p>CT scan image with MIP (Maximum Intensity Projection), 7 mm thickness, in sagittal (<b>a</b>) and transverse (<b>b</b>) planes, showing the nasal carcinoma with the 2 cm LeVeen electrode fully deployed inside.</p>
Full article ">Figure 3
<p>Multiplanar CT scan reconstruction at T0 (<b>a</b>–<b>c</b>) and at T2 (<b>d</b>–<b>f</b>), showing sagittal (<b>a</b>,<b>d</b>), transverse (<b>c</b>,<b>f</b>), and dorsal views (<b>b</b>,<b>e</b>). Overlain in light blue is the nasal carcinoma, a soft-tissue mass involving the turbinates. The nasal cavity is delineated by red arrows in all views.</p>
Full article ">
27 pages, 25472 KiB  
Article
Uncommon Nasal Mass Presentation: A Radiological Case Series
by Antonio Lo Casto, Francesco Lorusso, Ettore Palizzolo, Federico Sireci, Francesco Dispenza, Manfredi De Angelis, Angelo Immordino, Salvatore Gallina and Francesco Bencivinni
J. Pers. Med. 2024, 14(12), 1145; https://doi.org/10.3390/jpm14121145 - 9 Dec 2024
Viewed by 545
Abstract
Background: Nasal and paranasal sinus masses can arise from a wide range of conditions, both benign and malignant, as well as congenital or acquired. Diagnosing these masses is often challenging, requiring a combination of nasal endoscopy, imaging studies, and histopathological analysis. Initial imaging [...] Read more.
Background: Nasal and paranasal sinus masses can arise from a wide range of conditions, both benign and malignant, as well as congenital or acquired. Diagnosing these masses is often challenging, requiring a combination of nasal endoscopy, imaging studies, and histopathological analysis. Initial imaging frequently involves computed tomography or cone beam computed tomography (CBCT) to evaluate the bony anatomy of the nasal cavity and surrounding sinuses, while magnetic resonance imaging (MRI) is typically used for detailed assessment of soft tissues and to aid in differential diagnosis when the findings are inconclusive. Methods: This review examines nasal masses evaluated using CT, CBCT, and MRI, highlighting key imaging features that may assist in differential diagnosis. Results: For non-neoplastic lesions, examples include conditions such as rhinoliths, inverted mesiodens, and septal mucoceles. Benign and borderline tumors discussed encompass lobular capillary hemangioma, inverted papilloma, septal osteoma, chondromesenchymal hamartoma, hemangioma, hemangiopericytoma, antrochoanal polyp, sinonasal angiofibroma, ossifying fibroma, and lipoma. Malignant tumors addressed in this review include adenocarcinoma, esthesioneuroblastoma, non-Hodgkin lymphoma, melanoma, and sarcoma. Conclusions: Diagnosing nasal lesions represent a significant challenge for otolaryngologists. Imaging characteristics of nasal masses play a crucial role in narrowing down differential diagnoses before surgery. However, nasal endoscopy combined with biopsy remains the definitive diagnostic approach. Full article
(This article belongs to the Section Mechanisms of Diseases)
Show Figures

Figure 1

Figure 1
<p>Septal mucocele in a 49-year-old man who had been experiencing long-standing bilateral nasal obstruction. Axial T1 MR image (<b>a</b>) shows an oval mass with well-defined margins, high intensity content; due to fluid-proteinaceous content, in the middle-upper third of nasal cavity the mass causes partial nasal obstruction in both nasal cavities. On axial T1, fat saturation after intravenous Gd (<b>b</b>), the lesion shows peripheral wall enhancement. On coronal CBCT (<b>c</b>), the nasal septum bone is expanded by the mass (arrow), laterally displacing the middle-left turbinate. Endoscopic view (<b>d</b>) of the left nasal cavity shows the mucocele (asterisk) between nasal septum and middle left turbinate.</p>
Full article ">Figure 2
<p>Rinolith in a male patient with history of right nasal obstruction, worsening with fetid purulent, both front and rear, rhinorrhea for about 2 years. On axial and coronal CT (<b>a</b>,<b>b</b>), the right nasal cavity is obstructed by an irregular calcified, hyperdense lesion (arrow) with mucosal thickening and, due to the mass effect, the medial wall of the right maxillary sinus is slightly compressed and laterally bowed. Nasal endoscopy confirmed the presence of a huge rinolith with wooden consistency in the right nasal cavity adhering to the nasal septum.</p>
Full article ">Figure 3
<p>Inverted mesiodens in a 60-year-old male with unilateral nasal obstruction and blood discharge from his nose submitted to a CBCT. CBCT shows an inverted supernumerary tooth (inverted mesiodens) erupted into the right nasal cavity. The inverted mesiodens (yellow arrow), was carious with a periapical lesion (red arrowhead) and its crown was surrounded by reactive tissue with a rhinolith (white arrow).</p>
Full article ">Figure 4
<p>A lobular capillary hemangioma in a 61-year-old man with right nasal obstruction and epistaxis. On MR, an oval mass with smooth margins occupying most of the right nasal cavity, cranially attached to the ethmoid, is appreciable. On the T2 coronal image (<b>a</b>), the mass (arrow) shows a high signal intensity. On axial T1 fat saturation after intravenous Gd (<b>b</b>), the lesion (arrow) shows vivid enhancement with a unenhancing peripheral ring. Endoscopically, a slightly bleeding lesion, dark red in color, occupying almost the entire nasal cavity and implanted on the middle turbinate was evident.</p>
Full article ">Figure 5
<p>A nasal chondromesenchymal hamartoma in a patient with suspected rhinosinusitis. Coronal CBCT image (<b>a</b>) demonstrates, in the upper anterior third of the nasal septum, an oval lesion with well-defined margins and soft tissue density, extending in the upper third of both nasal cavities (arrow). No erosion of adjacent bony structure is visible. On MRI, in the T1 axial fat saturation image after intravenous Gd (<b>b</b>), a diffuse heterogeneous enhancement of the mass, with no enhancement of small cystic components, is appreciable (arrow).</p>
Full article ">Figure 6
<p>Ossifying fibroma in a 57-year-old woman with a clinical history of chronic sinusitis, who previously had undergone surgery of the left maxillary sinus. She was evaluated for the onset of painful and widespread left hemi-facial swelling, associated with fever, release of fetid purulent exudates and cacosmia. Rhinoscopy showed a lesion of bone consistency covered with normal-appearing mucosa occupying the lower portion of the left nasal cavity. Axial CT image (<b>a</b>) shows a lobulated and well-circumscribed mass, peripherally ossified (arrow); on coronal CT image (<b>b</b>), the mass (arrow) involves the lateral wall of left nasal cavity and caudally extents into the maxillary alveolar process in the periapical region of molar tooth 26. The patient underwent endoscopic re-excision of the lesion.</p>
Full article ">Figure 7
<p>Inverted papilloma in an 83-year-old woman presenting with right nasal obstruction for 2 years associated with fronto-temporal headache and epistaxis. Endoscopically, a lobulated mass protruding in the left nasal cavity was found. The axial CT image (<b>a</b>) shows a mass (arrow) located in the posterior third of the left nasal cavity, between the nasal septum and medial pterygoid plate, and protruding posteriorly through the left choana in the nasopharynx. No bony erosion is visible. On MRI, in the T1 axial fat saturation image after intravenous Gd (<b>b</b>), the mass shows intense heterogeneous enhancement, with typical cerebroid pattern (arrow); on the T2 axial image, the mass shows inhomogeneous, cerebroid aspect, with high intensity, alternating hypointense and hyperintense striation throughout the mass (arrow) (<b>c</b>).</p>
Full article ">Figure 8
<p>Osteoma as an incidental finding in a patient with rhinosinusitis. CT shows, in the upper anterior third of the nasal septum, an oval mass with smooth margin and bone density (arrow) visible on axial (<b>a</b>) and coronal (<b>b</b>) images. The mass extends into the left nasal cavity, partially obstructing the frontal recess.</p>
Full article ">Figure 9
<p>Hemangiopericytoma in a woman with epistaxis and bilateral nasal obstruction. On axial T1 MR image (<b>a</b>), the right nasal cavity is entirely occupied by an obstructing mass (arrow) with low–intermediate intensity and hyperintense hemorrhage areas (asterisk). Posteriorly, the mass, crossing the right choana, obstructs the nasopharynx lumen. On the axial fat saturation T1 after intravenous Gd image (<b>b</b>), the mass (arrow) is highly but inhomogeneously vascularized, with flow voids; on the axial T2 image (<b>c</b>), the mass (arrow) has medium–high intensity with an anterior low-intensity area, corresponding to hemorrhage; hypointense foci of flow void are also observed.</p>
Full article ">Figure 10
<p>Hemangioma in a patient with right nasal obstruction and epistaxis. During rhinoscopy, a smooth dark-red mass was noted. The axial CT image (<b>a</b>) shows a well-defined, oval mass in the upper third of the right nasal cavity (arrow); on MR, the mass (arrow) occupies the middle–upper third of the right nasal cavity, showing high intensity on the axial T2 image (<b>b</b>); on coronal fat saturation T1 after intravenous Gd (<b>c</b>), the mass (arrow) shows intense heterogeneous enhancement.</p>
Full article ">Figure 11
<p>Antrochoanal polyp in a patient with left nasal obstruction and suspected rhinosinusitis. At rhinoscopy, a yellowish translucent lesion, arising from left ostiomeatal complex and extending up to the nasopharynx, is observed. The coronal CT image (<b>a</b>) shows a soft tissue mass filling the lumen of the left maxillary sinus and extending through an accessory ostium of the medial sinus wall in the adjacent nasal cavity (arrow); no evident bony erosion is visible. The MR coronal T2 image (<b>b</b>) shows a polypoid mass (arrow) with high intensity in the left maxillary sinus, extending through the middle meatus into the left nasal cavity between the inferior turbinate (asterisk), laterally displaced, and septum. Sagittal T1 after intravenous Gd image (<b>c</b>) shows peripheral enhancement of the mass (arrow), extending posteriorly toward the choana in the nasopharynx lumen, behind the soft palate (asterisk); note the mucosal thickening of sphenoid and frontal sinuses due to obstruction of ostiomeatal complex.</p>
Full article ">Figure 12
<p>Lipoma in the inferior left nasal turbinate as an incidental finding on MRI. On axial T1 image (<b>a</b>), a millimetric oval spot in the inferior left nasal turbinate with high intensity (arrow) is observed; on axial STIR image (<b>b</b>), lipoma typically shows signal drop (arrow) due to fat signal suppression.</p>
Full article ">Figure 13
<p>Sinonasal tract angiofibroma in a 43-year-old patient with recurrent epistaxis and left nasal obstruction, anosmia, left cheek pain, and headache for approximately one year. MRI: coronal T2 image (<b>a</b>) shows a lobulated mass (arrow) with peripheral low-intensity rim, centered at the left maxillary sinus and extending through an accessory ostium into the left nasal cavity, totally obstructed; on the axial fat saturation T1 after intravenous Gd image (<b>b</b>), the mass (arrow) shows heterogeneous enhancement with contrast media blush in the left nasal fossa, suggesting active bleeding. On axial CT (<b>c</b>), the mass (arrow) has a soft tissue density, showing (<b>d</b>) intense but heterogeneous enhancement (arrow) after intravenous iodinated contrast medium administration.</p>
Full article ">Figure 14
<p>Non-Hodgkin lymphoma in a patient with monolateral left nasal obstruction. Rhinoscopy highlights a mass with a regular smooth surface responsible for raising mucosal lining of nasal floor. The axial CT image (<b>a</b>) shows a lobulated thickening of mucosal lining of the left lateral nasal wall (arrow), also extending to the maxillary sinus; note that lymphoid tissue permeates the adjacent cortical bone of the medial wall of the maxillary sinus. On the MRI coronal T2 fat saturation image (<b>b</b>), the lesion (arrow) shows high intensity, and extends into the lateral aspect of the left inferior turbinate, invading the left half of maxillary bone.</p>
Full article ">Figure 15
<p>Esthesioneuroblastoma in a 22-year-old girl with headache worsening in the supine position, associated with serous rhinorrhea and anosmia. She also had pain at the root of the nasal pyramid (widened and deformed) and eyelid edema. Endoscopically, at the level of the olfactory slit, an oval mass with a smooth surface and yellowish color, covered by a dense vascular reticule, was bilaterally evident. On the axial CT image (<b>a</b>), a mass (arrow) in both nasal cavities, with marked erosion of ethmoid and nasal bones, is visible; on the contrast-enhanced coronal CT image (<b>b</b>), the mass (arrow) shows intense and inhomogeneous enhancement, with massive erosion of ethmoid, involving the medial wall of the orbits and cribriform plate. MRI: on the coronal T2 image (<b>c</b>), the mass (arrow) shows low–intermediate intensity, with invasion of extraconic orbital fat; transcompartmental extension is also visible with intracranial extension in the olfactory groove; on the sagittal fat saturation T1 after intravenous Gd image (<b>d</b>), the tumor (arrow) shows heterogenous enhancement.</p>
Full article ">Figure 16
<p>Sinonasal intestinal-type adenocarcinoma in a patient with left nasal obstruction, epistaxis and headache. During rhinoscopy, an irregular-surfaced mass with high tendency to bleed was observed. MRI: the axial T2 image (<b>a</b>) shows a lobulated mass (arrow), in the left nasal cavity, obstructed, which expands the contiguous bony structure and medially erodes the nasal septum, invading the contralateral right nasal cavity; the mass causes obstruction of the ostiomeatal complex; mucocele of the left maxillary antrum is also visible; the coronal T1 after intravenous Gd image (<b>b</b>) shows heterogenous enhancement of the mass (arrow).</p>
Full article ">Figure 17
<p>Melanoma in a 67-year-old woman with left nasal obstruction. On axial T1 image (<b>a</b>), a medium–high-intensity oval formation (arrow) in the left antero-superior nasal fossa is appreciable; on the axial T1 after intravenous Gd image (<b>b</b>), the mass (arrow) shows inhomogeneous enhancement.</p>
Full article ">Figure 18
<p>Rhabdomyosarcoma in a 65-year-old woman with nasal rhinorrhea and epistaxis. MRI: the axial T1 after intravenous Gd image (<b>a</b>) shows a nodular tumor (arrow) with low vascularity, attached and eroding the third posterior part of the nasal septum; on the coronal T2 image (<b>b</b>), the mass (arrow) with intermediate intensity is located in the right nasal fossa floor, between the inferior turbinate and nasal floor; the coronal T2 image (<b>c</b>) shows bilaterally metastatic lymph nodes in II-III levels (arrows).</p>
Full article ">
11 pages, 2224 KiB  
Review
ECMO in the Management of Noncardiogenic Pulmonary Edema with Increased Inflammatory Reaction After Cardiac Surgery: A Case Report and Literature Review
by Raluca Elisabeta Staicu, Ana Lascu, Petru Deutsch, Horea Bogdan Feier, Aniko Mornos, Gabriel Oprisan, Flavia Bijan and Elena Cecilia Rosca
Diseases 2024, 12(12), 316; https://doi.org/10.3390/diseases12120316 - 4 Dec 2024
Viewed by 557
Abstract
Noncardiogenic pulmonary edema after cardiac surgery is a rare but severe complication. The etiology remains poorly understood; however, the issue may arise from multiple sources. Possible causes include a significant inflammatory response or an autoimmune process. Pulmonary edema resulting from noncardiac etiologies can [...] Read more.
Noncardiogenic pulmonary edema after cardiac surgery is a rare but severe complication. The etiology remains poorly understood; however, the issue may arise from multiple sources. Possible causes include a significant inflammatory response or an autoimmune process. Pulmonary edema resulting from noncardiac etiologies can necessitate extracorporeal membrane oxygenation (ECMO) because most of the cases present a substantial volume of fluid expelled from the lungs and the medical team must manage the inability to achieve effective ventilation. A 64-year-old patient with known heart disease was admitted to our clinic with acute pulmonary edema. His medical history included Barlow’s disease, severe mitral regurgitation (IIP2), moderate–severe tricuspid regurgitation, and moderate pulmonary hypertension. The patient had a coronary angiography performed in a prior hospitalization before the surgical intervention which indicated the absence of coronary lesions. Preoperative screening (nasal, pharyngeal exudate, inguinal pouch culture, and urine culture) was negative, with no active dental infections. The patient was stabilized, and 14 days post-admission, mitral and tricuspid valve repair was performed via a thoracoscopic approach. After being admitted to intensive care post-surgery, the patient quickly developed pulmonary edema, producing a large volume (4.5 L) of yellow secretions through the intubation tube followed by hemodynamic instability necessitating high doses of medications to support circulation but no cardiorespiratory arrest. Due to his worsening condition, the patient was urgently taken back to the operating room, where veno-venous extracorporeal membrane oxygenation (VV-ECMO) was initiated to support oxygenation and stabilize the patient. Full article
Show Figures

Figure 1

Figure 1
<p>Minithoracotomy mitral valve repair.</p>
Full article ">Figure 2
<p>Intraoperatory aspect of mitral valve repair.</p>
Full article ">Figure 3
<p>Color Doppler aspect of the repaired mitral valve.</p>
Full article ">Figure 4
<p>Post−operative aspect of the mitral valve (2D echocardiography).</p>
Full article ">Figure 5
<p>Chest X-ray suggestive of ARDS.</p>
Full article ">Figure 6
<p>Chest X-ray at 3 days of VV-ECMO, suggestive of a favorable outcome of the alveolar infiltrates.</p>
Full article ">
11 pages, 2627 KiB  
Article
Patient Age Predicts Nasal Septal Deviation in Orthognathic Surgery: A Non-Randomized Clinical Trial of 102 Participants
by Juergen Taxis, Henrik-Robert Florian, Gerardo Napodano, Maximilian Rink, Felix Nieberle, Katja Himmelstoß, Sophia R. Lindner, Tobias Ettl, Torsten E. Reichert and Waltraud Waiss
Medicina 2024, 60(12), 2000; https://doi.org/10.3390/medicina60122000 - 3 Dec 2024
Viewed by 399
Abstract
Background and Objectives: Orthognathic surgery is used to restore a correct anatomical and functional relationship between the jaws, with postoperative nasal septal deviation (NSD) being a common complication of Le Fort I osteotomy (LF-IO). The aim of this study was to evaluate [...] Read more.
Background and Objectives: Orthognathic surgery is used to restore a correct anatomical and functional relationship between the jaws, with postoperative nasal septal deviation (NSD) being a common complication of Le Fort I osteotomy (LF-IO). The aim of this study was to evaluate the occurrence of NSD after LF-IO and to identify possible risk factors. Materials and Methods: Pre- and postoperative cone beam computed tomography (CBCT) scans from 2018 to 2023 of 102 patients after LF-IO were analyzed. After categorizing the preoperative NSDs according to the Mladina classification, the next step was to measure the angle of deviation and classify the severity grades. Pre- and postoperative NSDs were compared using a paired Wilcoxon signed-rank test and postoperative changes in NSD were correlated with surgery-relevant characteristics by calculating Spearman’s correlation coefficients. Results: Postoperatively, an increase in NSD was observed in 62 cases and 35 patients showed a decrease. In both cases with an increase and a decrease in NSD, the preoperatively measured deviations showed a highly significant difference compared to postoperative NSDs (both p < 0.001). Age correlated significantly with increases in deviation (r = 0.28, p = 0.014, CI: −1.0–−0.068) and anterior maxillary displacement showed a significant correlation with a decrease in NSD (r = 0.296, p = 0.042, CI: 0.006–1.0). Gender, cranial and caudal movements of the maxilla had no influence on the results of the NSDs. Conclusions: LF-IO has an influence on NSD and can both intensify and attenuate it. In addition, the risk of an increase in nasal deviation after this surgical procedure rises with the patient’s age and decreases with anterior displacement of the maxilla. Full article
(This article belongs to the Special Issue Challenges and Features Facing Contemporary Orthognathic Surgery)
Show Figures

Figure 1

Figure 1
<p>Displacement of maxilla with LF-IO (<b>A</b>), downfracture (<b>B</b>), exposure of nasal septum (<b>C</b>), reduction in nasal septum (<b>D</b>), reduced nasal septum with resected part in forceps (<b>E</b>) and fixation of maxilla in new position with 4 L-shaped titanium plates (<b>F</b>).</p>
Full article ">Figure 2
<p>Angle measurement with increase in NSD in coronal view between two constructed lines (red line 1 between highest point of crista galli and most lateral structure at the transition from cartilaginous to bony nasal septum; red line 2 between highest point of crista galli and lower end of septum) and classification into grades. Pre- (<b>A</b>) and postoperative measurement (<b>B</b>) with grade I increase, pre- (<b>C</b>) and postoperative measurement (<b>D</b>) with grade II increase and pre- (<b>E</b>) and postoperative measurement (<b>F</b>) with grade III increase.</p>
Full article ">Figure 3
<p>Angle measurement with decrease in NSD in coronal view between two constructed lines (green line 1 between highest point of crista galli and most lateral structure at the transition from cartilaginous to bony nasal septum; green line 2 between highest point of crista galli and lower end of septum) and classified into grades. Pre- (<b>A</b>) and postoperative measurement (<b>B</b>) with grade I decrease, pre- (<b>C</b>) and postoperative measurement (<b>D</b>) with grade II decrease and pre- (<b>E</b>) and postoperative measurement (<b>F</b>) with grade III decrease.</p>
Full article ">Figure 4
<p>Pre- and postoperatively measured NSDs for increase (<b>A</b>) and decrease in septal deviation (<b>B</b>) with a highly statistically significant difference in each case (*** both <span class="html-italic">p</span> &lt; 0.001).</p>
Full article ">
11 pages, 419 KiB  
Review
Controversies in the Management of the Airway in Panfacial Fractures: A Literature Review and Algorithm Proposal
by Antonio Marí-Roig, Niall M. H. McLeod, Jan De Lange, Leander Dubois, Maria Fe García Reija, Bauke Van Minnen and Harald Essig
J. Clin. Med. 2024, 13(23), 7294; https://doi.org/10.3390/jcm13237294 - 30 Nov 2024
Viewed by 557
Abstract
Panfacial fractures are complex fractures involving multiple regions of the facial skeleton and may require multiple surgeries over a relatively short period. They are often associated with polytrauma and other injuries including neurotrauma, which require either immediate (ATLS) airway management, prolonged intubation, or [...] Read more.
Panfacial fractures are complex fractures involving multiple regions of the facial skeleton and may require multiple surgeries over a relatively short period. They are often associated with polytrauma and other injuries including neurotrauma, which require either immediate (ATLS) airway management, prolonged intubation, or repeated intubations for staged surgeries. The choice of airway for the surgical management of these fractures is difficult, as an assessment of the occlusion is required, and the central nasal complex and/or skull base may be involved, making classical orotracheal or nasotracheal intubation problematic. Submental intubation is increasingly reported as a method of airway management with the aim of avoiding a tracheostomy and its related complications. A review of the different techniques of airway management in the elective treatment of panfacial fractures was performed, focusing on the pros and cons of each method. Most articles were retrospective studies, with only one prospective study comparing submental intubation to tracheostomy in panfacial fractures. An algorithm for the management of the airway in panfacial fractures was presented, based on a sequential assessment of the existing airway, the surgical access required, and the need for prolonged or repeated intubation. Front of neck access, orotracheal and nasotracheal intubation, and submental intubation are all appropriate techniques in different circumstances, and the advantages and disadvantages of each are presented. Full article
(This article belongs to the Special Issue Updates and Challenges in Maxillo-Facial Surgery)
Show Figures

Figure 1

Figure 1
<p>Algorithm for airway management in panfacial fractures.</p>
Full article ">
14 pages, 2133 KiB  
Systematic Review
Temporoparietal Fascia Flap (TPFF) in Extended Endoscopic Transnasal Skull Base Surgery: Clinical Experience and Systematic Literature Review
by Martina Offi, Pier Paolo Mattogno, Ginevra Federica D’Onofrio, Simona Serioli, Federico Valeri, Giuseppe Maria Della Pepa, Vincenzo Arena, Claudio Parrilla, Sabrina Chiloiro, Francesco D’Argento, Marco Gessi, Alessandro Pedicelli, Liverana Lauretti, Gaetano Paludetti, Jacopo Galli, Alessandro Olivi, Mario Rigante and Francesco Doglietto
J. Clin. Med. 2024, 13(23), 7217; https://doi.org/10.3390/jcm13237217 - 27 Nov 2024
Viewed by 520
Abstract
Background and Objectives: The temporoparietal fascia flap (TPFF) has recently emerged as an option for skull base reconstruction in endoscopic transnasal surgery when vascularized nasal flaps are not available. This study provides a systematic literature review of its use in skull base surgery [...] Read more.
Background and Objectives: The temporoparietal fascia flap (TPFF) has recently emerged as an option for skull base reconstruction in endoscopic transnasal surgery when vascularized nasal flaps are not available. This study provides a systematic literature review of its use in skull base surgery and describes a novel cohort of patients. Methods: PRISMA guidelines were used for the review. Patients undergoing skull base reconstruction with TPFF in our center from May 2022 to April 2024 were retrospectively included. Data were collected on pre- and post-operative clinical and radiological features, histology, surgical procedures, and complications. Results: Sixteen articles were selected, comprising 42 patients who underwent TPFF reconstruction for treatment of complex skull base pathologies. In total, 5 of 358 patients (0.9%) who underwent tumor resection via endoscopic transanal surgery in the study period in our institution required TPFF. All had been previously treated with surgery and radiation therapy for different pathologies (three chordomas, one giant pituitary neuroendocrine tumor (PitNET), and one sarcoma). Post-operative complications included CSF leak, which resolved after flap revision, and an internal carotid artery pseudoaneurysm requiring endovascular embolization. Conclusions: TPFF is an effective option for skull base reconstruction in complex cases and should be part of the armamentarium of the skull base surgeon. Full article
(This article belongs to the Special Issue State of the Art—Treatment of Skull Base Diseases (Second Edition))
Show Figures

Figure 1

Figure 1
<p><b>First and final nasal phases.</b> (<b>A</b>) Opening of the maxillary sinus. (<b>B</b>) Opening of the anterior wall of the maxillary sinus. (<b>C</b>) Opening of the posterior wall of the maxillary sinus. (<b>D</b>) Identification of the maxillary artery. (<b>E</b>) Sectioning of the maxillary artery. (<b>F</b>) Identification of the temporal muscle, the infraorbital nerve and artery. (<b>G</b>) Passage of the Blue Rhino<sup>®</sup> guide (<span class="html-italic">see text for details</span>) for flap transposition. (<b>H</b>) Positioning of the folded TPFF to cover the bone defect. <span class="html-italic">Abbreviations:</span> IN, infraorbital nerve; MA, maxillary artery; MSm, medial wall of maxillary sinus; MSp, posterior wall of maxillary sinus; TM, temporal muscle.</p>
Full article ">Figure 2
<p><b>Cranial phases.</b> (<b>A</b>) The lines depict the different landmarks on the skin. Blue: Pitanguy’s line, Yellow: Temporal branch of the facial nerve, Black: Zygomatic arch, Red: STA. (<b>B</b>) Red dashed line: Incision. (<b>C</b>) After subcutaneous dissection, identification of STA, frontal (FB) and posterior branches (PB). (<b>D</b>) Incision of the flap utilizing the posterior branch of the STA with dissection from the temporal muscle fascia (TM). (<b>E</b>) TPFF flap with identification of FB and PB branches of the STA. (<b>F</b>) Subfascial dissection. (<b>G</b>) Placement of the Rhino percutaneous tracheostomy dilator in the infratemporal fossa. (<b>H</b>) Suturing of the TPFF to the guide. (<b>I</b>) Progressive transposition of the TPFF through the infratemporal fossa, pterygoid fossa, and into the nasal cavity by pulling the guide from the maxillary sinus into the nasal cavity. (<b>J</b>) Complete transposition of the TPFF without compression or bending of the flap base. <span class="html-italic">Abbreviations:</span> FB, frontal branch of superficial temporal artery; FC, facial nerve; PB, parietal branch of superficial temporal artery; STA, superficial temporal artery; ZA, zygomatic arch; TM, temporal muscle.</p>
Full article ">Figure 3
<p>PRISMA flowchart of the systematic literature review.</p>
Full article ">Figure 4
<p><b>First and final nasal phases.</b> (<b>A</b>) Defect of the previous surgery, with necrosis of the previous Hadad septal nose flap and recurrent CSF fistula. (<b>B</b>) Opening of the posterior wall of the maxillary sinus. (<b>C</b>) Identification and coagulation of the maxillary artery. (<b>D</b>) Passage of the Blue Rhino<sup>®</sup> guide for flap transposition. (<b>E</b>) Preparation of the folded TPFF. (<b>F</b>) Positioning of the folded TPFF to cover the bone defect. <span class="html-italic">Abbreviations:</span> MA, maxillary artery; MSp, posterior wall of maxillary sinus.</p>
Full article ">Figure 5
<p><b>Cranial phases.</b> (<b>A</b>) Preparation and incision of the flap utilizing the posterior branch of the STA with dissection from the temporal muscle fascia (TM) and placement of the Rhino percutaneous tracheostomy dilator in the infratemporal fossa. (<b>B</b>) Suturing of the TPFF to the guide. (<b>C</b>) Progressive transposition of the TPFF into the nasal cavity by pulling the guide until the guide completely comes out of the nasal cavity, then the suture is cut. (<b>D</b>) Complete transposition of the TPFF without compression or bending of the flap base (<span class="html-italic">white arrow</span>). <span class="html-italic">Abbreviations:</span> TM, temporal muscle.</p>
Full article ">
8 pages, 277 KiB  
Article
Comparison of the Effects of Lidocaine Versus Magnesium Infusion on Quality of Recovery After Nasal Bone Fracture Surgery
by Eun Kyung Choi, Jongyoon Baek and Kyu Jin Chung
Medicina 2024, 60(12), 1939; https://doi.org/10.3390/medicina60121939 - 25 Nov 2024
Viewed by 418
Abstract
Background and Objectives: Postoperative recovery from general anesthesia is a multidimensional process, and patient-centered outcome assessment should be considered an important indicator of recovery quality. This study compared the effectiveness of intraoperative lidocaine and magnesium on postoperative recovery in nasal bone fracture [...] Read more.
Background and Objectives: Postoperative recovery from general anesthesia is a multidimensional process, and patient-centered outcome assessment should be considered an important indicator of recovery quality. This study compared the effectiveness of intraoperative lidocaine and magnesium on postoperative recovery in nasal bone fracture surgery, using the quality of recovery-40 questionnaire (QoR-40) to assess recovery quality and pain intensity. Materials and Methods: A total of 74 patients scheduled for elective closed reduction surgery for isolated nasal bone fracture were assigned to the intraoperative infusions of lidocaine or magnesium. Immediately after anesthetic induction, 1.5 mg/kg lidocaine or 20 mg/kg magnesium was administered over 10 min, followed by a continuous infusion of 2 mg/kg/h lidocaine or 20 mg/kg/h magnesium until the end of the surgery. The primary outcome variable was the QoR-40 survey on postoperative day 1. The secondary outcome variables included postoperative pain intensity, sedation score, the incidence of postoperative nausea and vomiting, and other side effects. Results: The global QoR-40 score at postoperatively 24 h was comparable between the intraoperative lidocaine and magnesium groups. Postoperative pain 30 min after surgery was significantly lower in the lidocaine group than in the magnesium group (p = 0.01), along with lower rescue analgesic consumption (p = 0.003), but pain intensity was not different at other time points (2, 6, and 24 h). The incidence of nausea and vomiting and the sedation score in the post-anesthetic care unit were not significantly different between the two groups. Conclusions: Intraoperative lidocaine and magnesium had no difference in the scores of postoperative QoR-40, but lidocaine was associated with lower postoperative pain scores and analgesic requirement in comparison to magnesium in the closed reduction of nasal bone fractures. Full article
(This article belongs to the Section Intensive Care/ Anesthesiology)
14 pages, 5065 KiB  
Article
Accuracy Evaluation of a Three-Dimensional Face Reconstruction Model Based on the Hifi3D Face Model and Clinical Two-Dimensional Images
by Yujia Xiao, Bochun Mao, Jianglong Nie, Jiayi Liu, Shuo Wang, Dawei Liu and Yanheng Zhou
Bioengineering 2024, 11(12), 1174; https://doi.org/10.3390/bioengineering11121174 - 21 Nov 2024
Viewed by 606
Abstract
Three-dimensional (3D) facial models have been increasingly applied in orthodontics, orthognathic surgery, and various medical fields. This study proposed an approach to reconstructing 3D facial models from standard orthodontic frontal and lateral images, providing an efficient way to expand 3D databases. A total [...] Read more.
Three-dimensional (3D) facial models have been increasingly applied in orthodontics, orthognathic surgery, and various medical fields. This study proposed an approach to reconstructing 3D facial models from standard orthodontic frontal and lateral images, providing an efficient way to expand 3D databases. A total of 23 participants (average age 20.70 ± 5.36 years) were enrolled. Based on the Hifi3D face model, 3D reconstructions were generated and compared with corresponding face scans to evaluate their accuracy. Root mean square error (RMSE) values were calculated for the entire face, nine specific facial regions, and eight anatomical landmarks. Clinical feasibility was further assessed by comparing six angular and thirteen linear measurements between the reconstructed and scanned models. The RMSE of the reconstruction model was 2.00 ± 0.38 mm (95% CI: 1.84–2.17 mm). High accuracy was achieved for the forehead, nose, upper lip, paranasal region, and right cheek (mean RMSE < 2 mm). The forehead area showed the smallest deviation, at 1.52 ± 0.88 mm (95% CI: 1.14–1.90 mm). In contrast, the lower lip, chin, and left cheek exhibited average RMSEs exceeding 2 mm. The mean deviation across landmarks was below 2 mm, with the Prn displaying the smallest error at 1.18 ± 1.10 mm (95% CI: 0.71–1.65 mm). The largest discrepancies were observed along the Z-axis (Z > Y > X). Significant differences (p < 0.05) emerged between groups in the nasolabial, nasal, and nasofrontal angles, while the other 13 linear and 3 angular measurements showed no statistical differences (p > 0.05). This study explored the feasibility of reconstructing accurate 3D models from 2D photos. Compared to facial scan models, the Hifi3D face model demonstrated a 2 mm deviation, with potential for enriching 3D databases for subjective evaluations, patient education, and communication. However, caution is advised when applying this model to clinical measurements, especially angle assessments. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Colour-coded deviation analysis map of a typical subject. The deviation of all the landmarks is shown as follows: Prn = pronasale; Ls = labrale superius; Li = labrale inferius; Lch = left cheilion; Rch = right cheilion; Pg’ = pogonion of soft tissue; Gn’ = gnathion of soft tissue; and Me’ = menton of soft tissue.</p>
Full article ">Figure 2
<p>Three-dimensional soft tissue measurements. (a) Outercanthal Width; (b) Labial Fissure Width (ChiL-ChiR); (c) nasolabial angle (Prn-Sn-Ls); (d) Facial Convexity (Gl-Sn-Pg’); (e) Total Facial Convexity (Gl-Prn-Pg’); (f) Outer Canthal, Nasal Angle; (g) Nasal Angle (N’-Prn-Sn); (h) Nasofrontal Angle (Gl-N’-Prn); (i) Philtral Length (Sn-Ls); (j) Philtral Width (CphR-CphL); (k) Philtral Depth; (l) Facial Height (N’-Gn’); (m) Upper Lip Height (Sn-Stos); (n) Lower Lip Height (Stoi-Sl); (o) Upper lip Protrusion (|Prn-Ls|z); (p) Lower lip Protrusion (|Prn-Li|z); (q) Mentolabial furrows depth (|Li-Sl|z); (r) Thickness of upper vermilion (|Ls-Stos|z); (s) Thickness of lower vermilion (|Li-Stoi|z).</p>
Full article ">Figure 3
<p>Root mean square error (RMSE) of different regions of the reconstruction models.</p>
Full article ">Figure 4
<p>Cloud maps depicting 3D deviations between face scan models and reconstructions for three patients with varied facial profiles: straight (<b>a</b>), concave (<b>b</b>), and convex (<b>c</b>).</p>
Full article ">Figure 5
<p>Best and worst reconstruction results: (<b>a</b>) best reconstruction outcome; (<b>b</b>) worst reconstruction outcome.</p>
Full article ">Figure 6
<p>Three-Dimensional deviation of eight landmarks (mean ± 95% CI, mm; D: deviation; Dx: horizontal deviation; Dy: vertical deviation; Dz: sagittal deviation; Prn: pronasale; Ls: labrale superius; Li: labrale inferius; Lch: left cheilion; Rch: right cheilion; Pg’: pogonion of soft tissue; Gn’: gnathion of soft tissue; Me’: menton of soft tissue).</p>
Full article ">
13 pages, 7843 KiB  
Article
The Effects of Mepolizumab on CRSwNP: Real-Life Evidence
by Elena Cantone, Bernardino Cassiano, Paolo Pezzella, Mario Brandon Russo and Aikaterini Detoraki
J. Pers. Med. 2024, 14(11), 1112; https://doi.org/10.3390/jpm14111112 - 20 Nov 2024
Viewed by 747
Abstract
Background: This study aims to evaluate the efficacy and safety of mepolizumab in the treatment of severe uncontrolled CRSwNP with or without comorbid asthma in a real-life setting over the first six months of therapy. Methods: A total of 45 patients [...] Read more.
Background: This study aims to evaluate the efficacy and safety of mepolizumab in the treatment of severe uncontrolled CRSwNP with or without comorbid asthma in a real-life setting over the first six months of therapy. Methods: A total of 45 patients with nasal polyps with or without comorbid asthma were treated with mepolizumab (100 mg q4w) for 6 months. The following outcomes were assessed before therapy (V0), and after 6 months (V1): endoscopic nasal polyp score (NPS), nasal congestion score (NCS), sinonasal outcome test (SNOT-22), visual analog scale (VAS), nasal flow rate (PNIF), olfactory test (SS-I), and asthma control test (ACT). Blood eosinophil count, oral steroid intake, and rescue surgery were also measured. Results: We found a statistically significant improvement in NPS, NCS, SNOT-22, overall VAS, PNIF, SS-I, and ACT. In addition, we observed a decrease in blood eosinophils count. Mepolizumab was well tolerated, and no patients interrupted the treatment during the follow up. Conclusions: Our real-life study confirmed the efficacy and tolerance of mepolizumab prescribed for CRSwNP with or without asthma. The safety profile of mepolizumab was consistent with previous reports. Full article
(This article belongs to the Section Clinical Medicine, Cell, and Organism Physiology)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>NPS (nasal polyp score) decreases after 6 months of therapy (V<sup>0</sup>: baseline; V<sup>1</sup>; 6 months) (5.2 ± 3.2 SD to 2.5 ± 1.4 SD; <span class="html-italic">p</span> = 0.004).</p>
Full article ">Figure 2
<p>NCS (nasal congestion score) decreases after 6 months of therapy (V<sup>0</sup>: baseline; V<sup>1</sup>; 6 months) (2.8 ± 0.3 SD to 1.8 ± 0.9 SD; <span class="html-italic">p</span> = 0.02).</p>
Full article ">Figure 3
<p>PNIF (pick nasal inspiratory flow) decreases after 6 months of therapy (V<sup>0</sup>: baseline; V<sup>1</sup>; 6 months) (58.7 ± 18.8 SD to 100 ± 33.9; <span class="html-italic">p</span> = 0.009).</p>
Full article ">Figure 4
<p>The overall VAS (the overall VAS symptoms score combines scores for nasal obstruction, rhinorrhea, facial pain, and loss of smell) decreases after 6 months of therapy (V<sup>0</sup>: baseline; V<sup>1</sup>; 6 months) (6.53 ± 3.1 SD to 4.8 ± 2 SD; <span class="html-italic">p</span> = 0.02).</p>
Full article ">Figure 5
<p>The blood eosinophil (EOS) count decreases after 6 months of therapy (V<sup>0</sup>: baseline; V<sup>1</sup>; 6 months) (421.0 ± 302.7 SD to 75.0 ± 71.4 SD; <span class="html-italic">p</span> = 0.001).</p>
Full article ">Figure 6
<p>QoL improvement. The SNOT-22 (sinonasal outcome) decreases after 6 months of therapy (V<sup>0</sup>: baseline; V<sup>1</sup>; 6 months) (61.3 ± 24.1 SD to 19.5 ± 8.4 SD; <span class="html-italic">p</span> = 0.001).</p>
Full article ">Figure 7
<p>The SS-I (sniffin’ sticks identification test) increases after 6 months of therapy (V<sup>0</sup>: baseline; V<sup>1</sup>; 6 months) (4.1 ± 2.3 SD to 7.5 ± 2.8 SD; <span class="html-italic">p</span> = 0.02).</p>
Full article ">
15 pages, 1420 KiB  
Systematic Review
Update on the Biological and Clinical Relevance of Mast Cells in Chronic Rhinosinusitis with Nasal Polyps
by Luca Giovanni Locatello, Silvia Tonon, Vincenzo Mele, Simone Santini, Cesare Miani and Carlo Ennio Michele Pucillo
Biomedicines 2024, 12(11), 2647; https://doi.org/10.3390/biomedicines12112647 - 20 Nov 2024
Viewed by 669
Abstract
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a common inflammatory disorder whose complex immunopathogenesis has yet to be fully elucidated. Endotype-2 CRSwNP is the most common form of disease where eosinophils are the main drivers of inflammation. Traditional treatments for CRSwNP have centered [...] Read more.
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a common inflammatory disorder whose complex immunopathogenesis has yet to be fully elucidated. Endotype-2 CRSwNP is the most common form of disease where eosinophils are the main drivers of inflammation. Traditional treatments for CRSwNP have centered around intranasal or systemic corticosteroids and endoscopic sinus surgery (ESS). However, recent advancements in targeted therapies have introduced novel biological agents that specifically target key inflammatory mediators such as IL-4, IL-5, and IL-13. These biologics offer promising options for patients with CRSwNP, particularly those who do not respond adequately to conventional treatments. Nonetheless, some patients do not satisfactorily respond to these drugs because of an insufficient blockade of the inflammatory process. The mast cell (MC) is another important (and somehow neglected) actor in the pathogenesis of CRSwNP, and the latest clinical and translational evidence in this field has been reviewed in the present paper. Full article
(This article belongs to the Section Immunology and Immunotherapy)
Show Figures

Figure 1

Figure 1
<p>PRISMA flowchart for the selection of the articles discussed in the present review.</p>
Full article ">Figure 2
<p>Based on single-cell data, it has been shown that healthy nasal tissue is characterized by the presence of MC<sub>TCs</sub> (MC tryptase and chymase positive) with the potential to regulate type 2 inflammation, whereas in polyp tissue, MC<sub>Ts</sub> (tryptase only) are also found. In particular, in this pathological setting, MCs are capable of producing pro-inflammatory cytokines such as IL-5 and IL-13, and also PGD2. In both contexts, MCs can be activated by the alarmin IL-33 or by IgE-mediated antigen stimulation.</p>
Full article ">Figure 3
<p>mAb for the direct or indirect interference of MC function in the context of CRSwNP. The activity of mast cells can be inhibited by preventing the binding of immunoglobulin E (IgE) to the Fc epsilon receptor 1 (FceRI). This can be achieved through the use of omalizumab, which binds directly to free IgE, or by preventing the production of IgE by plasma cells through the inhibition of interleukin 4 (IL-4) and IL-13 signaling. Additionally, the function of mast cells can be modulated by preventing the binding of IL-5 with mepolizumab or by directly blocking IL5R with benralizumab.</p>
Full article ">
5 pages, 1378 KiB  
Case Report
Recurrent Nasal Polyposis and Bifid Epiglottis in a Child with Bardet–Biedl Syndrome Ciliopathy
by Natalia Fourla, Nikolaos Drimalas and Ioannis Michael Vlastos
Sinusitis 2024, 8(2), 63-67; https://doi.org/10.3390/sinusitis8020008 - 14 Nov 2024
Viewed by 1232
Abstract
Bardet–Biedl syndrome (BBS) is a genetic disease caused by mutations of the BBS genes that encode proteins involved in cilia functioning. It can present with major and/or minor clinical manifestations, such as rod–cone dystrophy, polydactyly, obesity, speech delay, anosmia, congenital heart disease and [...] Read more.
Bardet–Biedl syndrome (BBS) is a genetic disease caused by mutations of the BBS genes that encode proteins involved in cilia functioning. It can present with major and/or minor clinical manifestations, such as rod–cone dystrophy, polydactyly, obesity, speech delay, anosmia, congenital heart disease and genital and renal abnormalities. Diagnosis of this rare disease is based on clinical criteria and can be confirmed with molecular genetic testing. Although BBS is a ciliopathy, nasal polyposis has never before been reported in patients with this condition. This article presents the case of a 12-year-old male patient admitted with symptoms of retinopathy, development delay, anosmia, bifid epiglottis and recurrent nasal polyposis. After several clinical, imaging and genetic examinations, the patient was diagnosed with BBS. His nasal symptoms were treated with functional endoscopic sinus surgery and long-term antibiotic therapy, whereas courses of topical antibiotics as well as topical and systemic corticosteroids had no effect. As a conclusion, it is a rare case that presents new clinical manifestations (nasal polyps) that can be related to BBS and possible effective treatments. Full article
Show Figures

Figure 1

Figure 1
<p>Image of laryngoscopy and of the bifid epiglottis.</p>
Full article ">Figure 2
<p>Preoperative CT scan image.</p>
Full article ">Figure 3
<p>Preoperative CT scan image.</p>
Full article ">
13 pages, 4597 KiB  
Article
Anatomical Measurements of the Malar Bone for Safe Zygomatic Implant Placement: A Study on Donated Bodies
by Carlo Barausse, Pietro Felice, Roberto Pistilli, Gerardo Pellegrino, Lorenzo Bonifazi, Subhi Tayeb, Antonietta Fazio, Maria Vittoria Marvi, Lucia Manzoli and Stefano Ratti
J. Clin. Med. 2024, 13(22), 6798; https://doi.org/10.3390/jcm13226798 - 12 Nov 2024
Viewed by 621
Abstract
Background: The malar bone provides an anchorage point for zygomatic implants, avoiding invasive reconstructive surgeries in the fixed rehabilitation of fully edentulous and severely atrophic maxillae. The limited bone volume, however, requires precise implant placement to prevent complications related to nearby anatomical [...] Read more.
Background: The malar bone provides an anchorage point for zygomatic implants, avoiding invasive reconstructive surgeries in the fixed rehabilitation of fully edentulous and severely atrophic maxillae. The limited bone volume, however, requires precise implant placement to prevent complications related to nearby anatomical structures. This observational cross-sectional study aims to measure the malar and zygomatic arch bones and their distances from critical anatomical landmarks to guide surgeons in safe zygomatic implant placement. Methods: Dissections were performed bilaterally on 29 heads from human donated bodies in a cross-sectional observational study. Key landmarks evaluated include the infraorbital foramen (IF), pyriform nasal aperture (PNA), infraorbital margin (IM), zygomaticofacial foramen (ZFF), anterior end (A), and the most protruding point of the zygomatic arch (B). Measurements included IF-PNA, IF-IM, IF-ZFF, ZFF-IM, A-B, and orbital floor depth (OFD). Results: Significant findings showed IF-PNA was greater in males (18.66 ± 2.63 mm, p = 0.001), and IF-ZFF varied between sides (26.72 ± 8.7 mm, p = 0.002). ZFF-IM was larger in males (7.43 ± 2.09 mm, p < 0.001). Heights and thicknesses were also assessed, with significant side differences observed. Conclusions: These findings underscore the importance of understanding precise anatomical distances for successful implant placement. The study provides essential data to enhance surgical planning and training, ensuring safer procedures and minimizing the risk of complications. Full article
(This article belongs to the Special Issue Dental Implantology: Clinical Updates and Perspectives)
Show Figures

Figure 1

Figure 1
<p>Weber–Ferguson incision used to allow access to the maxilla and the zygomatic bone and arch.</p>
Full article ">Figure 2
<p>Anatomical landmarks involved in zygomatic surgery that were taken into consideration: (<b>a</b>) infraorbital nerve, (<b>b</b>) overview of all the considered points [infraorbital foramen (IF), pyriform nasal aperture (PNA), external orbital border (EOB) or infraorbital margin, zygomaticofacial foramen (ZFF), anterior end of the zygomatic arch (A), most protruding point of the zygomatic arch (B)].</p>
Full article ">Figure 3
<p>(<b>a</b>,<b>b</b>) Examples of linear measurements taken with a digital caliper with a resolution of 0.1 mm [infraorbital foramen (IF), pyriform nasal aperture (PNA), infraorbital margin (IM)].</p>
Full article ">Figure 3 Cont.
<p>(<b>a</b>,<b>b</b>) Examples of linear measurements taken with a digital caliper with a resolution of 0.1 mm [infraorbital foramen (IF), pyriform nasal aperture (PNA), infraorbital margin (IM)].</p>
Full article ">Figure 4
<p>Linear distances between the infraorbital foramen (IF) and the two zygomaticofacial foramens (ZFFs).</p>
Full article ">Scheme 1
<p>Distribution of zygomaticofacial foramina in the studied sample.</p>
Full article ">Scheme 2
<p>Mean distances (mm) with standard deviations for various anatomical measurements related to the malar bone and zygomatic arch. The measurements include infraorbital foramen to pyriform nasal aperture (IF-PNA), infraorbital foramen to orbital floor (IF-OF), infraorbital foramen to zygomaticofacial foramen (IF-ZFF), zygomaticofacial foramen to orbital floor (ZFF-OF), height at point A (A-Height), distance from point A to point B (A-B), thickness at point A (A-Thickness), height at point B (B-Height), thickness at point B (B-Thickness), and orbital floor depth (OFD).</p>
Full article ">Scheme 3
<p>Linear measurements for infraorbital foramen to external border of the orbital floor (IF-OF), orbital floor depth (OFD), and their difference in terms of absolute values. The red line represents the minimum value found in the differences between the two measurements.</p>
Full article ">Scheme 4
<p>Boxplot for the distribution of measurements based on sex (male and female); (♦: outliers data).</p>
Full article ">Scheme 5
<p>Boxplot for the distribution of measurements based on the type of edentulism (total or partial); (♦: outliers data).</p>
Full article ">Scheme 6
<p>Boxplot for the distribution of measurements based on the side (right and left); (♦: outliers data).</p>
Full article ">Scheme 7
<p>The heatmap visualizes the <span class="html-italic">p</span>-values derived from a mixed-effects model using REML estimation for different measurements and variables. Each cell represents the <span class="html-italic">p</span>-value of a specific measurement–variable pair. The cells are color-coded using a cool–warm palette, with cooler colors indicating lower <span class="html-italic">p</span>-values and warmer colors indicating higher <span class="html-italic">p</span>-values.</p>
Full article ">
14 pages, 1659 KiB  
Article
Assessing the Efficacy and Safety of Extubation Protocols in the Intensive Care Unit Following Transoral Robotic Surgery for Obstructive Sleep Apnea Syndrome: A Retrospective Cohort Study
by Andreaserena Recchia, Marco Cascella, Massimiliano Copetti, Alessio Barile, Elena Giovanna Bignami, Aurelio D’Ecclesia, Antonio Izzi, Aldo Manuali, Vincenzo Marchello, Giuseppe Mincolelli and Alfredo Del Gaudio
J. Clin. Med. 2024, 13(22), 6786; https://doi.org/10.3390/jcm13226786 - 11 Nov 2024
Viewed by 611
Abstract
Background: There is a notable lack of protocols addressing extubation techniques in transoral robotic surgery (TORS) for obstructive sleep apnea (OSA). Methods: This retrospective cohort study enrolled patients who underwent TORS for OSA between March 2015 and December 2021 and were [...] Read more.
Background: There is a notable lack of protocols addressing extubation techniques in transoral robotic surgery (TORS) for obstructive sleep apnea (OSA). Methods: This retrospective cohort study enrolled patients who underwent TORS for OSA between March 2015 and December 2021 and were managed with different extubation approaches. The patients were divided into two groups: high-flow nasal cannula (HFNC) therapy and conventional oxygen therapy. The use of an airway exchange catheter (AEC) was investigated. Results: The application of HFNC use versus conventional oxygen therapy led only to a statistical reduction in extubation time (p = 0.024); length of stay in the intensive care unit (ICU) and the episodes of desaturation below 95% were reduced, but data are non-statistically significant. Similarly, the application of an AEC led to a reduction in extubation time in hours (p = 0.008) and length of stay in the ICU (p = 0.024). Conclusions: In patients with OSA who underwent TORS, the use of an HFNC, with or without an AEC, resulted in a significant reduction in extubation time without major adverse events. Additionally, HFNC utilization may decrease desaturation episodes during extubation. Despite limitations, based on the findings of this preliminary investigation, the combination of an HFNC and an AEC emerges as a promising strategy for enhancing the safety and efficacy of extubation protocols in this patient population. Full article
(This article belongs to the Section Pulmonology)
Show Figures

Figure 1

Figure 1
<p>The course of the retrospective study. Abbreviations: airway exchange catheter, AEC; high-flow nasal cannula, HFNC; intensive care unit, ICU.</p>
Full article ">Figure 2
<p>Study flowchart. Abbreviations: TORS, transoral robotic surgery; ICU, intensive care unit; HFNC, high-flow nasal cannula.</p>
Full article ">Figure 3
<p>Bar plot of the propensity scores (PSs) distribution between the two groups. The x-axis represents the two groups being compared (Conventional and HFNC). The y-axis represents the density or proportion of patients within specific ranges of PSs. The bars indicate the distribution of propensity scores for each group. Each bar’s height corresponds to the proportion of patients in that group who fall within a specific range of PSs. The alignment of bars between the two groups shows how similar the groups are in terms of their PSs after matching. The graph shows that the PSs of the two groups have been balanced. The bars for the Conventional and HFNC groups should align closely, indicating that the matching process has successfully created comparable groups.</p>
Full article ">Figure 4
<p>Extubation time with and without high-flow nasal cannula (HFNC). Legend: * <span class="html-italic">p</span> &lt; 0.005.</p>
Full article ">Figure 5
<p>Extubation times with and without an airway exchange catheter (AEC). Legend: * <span class="html-italic">p</span> &lt; 0.005.</p>
Full article ">Figure 6
<p>Intensive care unit (ICU) stays with and without an airway exchange catheter (AEC). Legend: * <span class="html-italic">p</span> &lt; 0.005.</p>
Full article ">
16 pages, 850 KiB  
Systematic Review
Biphenotypic Sinonasal Sarcoma: Literature Review of a Peculiar Pathological Entity—The Neurosurgical Point of View
by Sergio Corvino, Giuseppe Corazzelli, Giuseppe Mariniello, Adriana Iuliano, Roberto Altieri, Giuseppe Pontillo, Diego Strianese, Manlio Barbarisi, Andrea Elefante and Oreste de Divitiis
Cancers 2024, 16(22), 3747; https://doi.org/10.3390/cancers16223747 - 6 Nov 2024
Viewed by 605
Abstract
Background: Biphenotypic sinonasal sarcoma (BSNS) is a low-grade tumor of the sinonasal tract with frequent extension to the orbit and skull base. Due to its rare incidence and recent histopathological and molecular characterization, little data are available in regard to its natural history, [...] Read more.
Background: Biphenotypic sinonasal sarcoma (BSNS) is a low-grade tumor of the sinonasal tract with frequent extension to the orbit and skull base. Due to its rare incidence and recent histopathological and molecular characterization, little data are available in regard to its natural history, treatment and surveillance protocol. Methods: A comprehensive literature review in Embase online electronic databases on BSNS was made. The analyzed factors included the patients’ sex and age, presenting symptoms and signs, anatomical origin and pattern of growth of the tumor, immunohistochemical and molecular features, time to treatment, type of treatment, surgical approach, extent of resection, peri- and post-operative complications, adjuvant therapies, clinical outcome, recurrence and overall survival rates. Results: This literature review involved 34 studies for an overall series of 149 cases of BSNS. The female (66.9%) and middle-aged populations (median 54.88 years old) were mainly affected. The most frequent clinical onset was nasal obstruction (81%), followed by facial discomfort (44%), epistaxis (15.5%) and ocular impairment (14.3%). Ethmoid sinus (67.8%) and nasal cavity (45.4%) were the most common anatomical site of tumor origin, while an extension to the orbit and skull base was registered in 28.7% and 24.5% of cases. Surgery was the main treatment, especially in the form of endoscopic endonasal approach (56.9%), and allowed for gross total resection in 79% of cases. The recurrence rate was 26.2%; three cases of tumor-related death were reported. Median follow-up was 4.6 years. Conclusions: Biphenotypic sinonasal sarcoma is a rare and unique tumoral entity in terms of biological and clinical behavior. Based on the current knowledge, surgery plays the leading role in treatment, accounting for gross total tumor resection in most cases, allowing for clinical symptom and sign resolution and presenting a low rate of perioperative complications. The type of approach and the aim of surgery should be assessed case by case according to patient and pathology features and the surgeon’s experience, as well as the aim of the treatment. Further studies including large surgical series and with long follow-up are required to define prognostic factors and guidelines of treatment for this peculiar pathological entity. Full article
(This article belongs to the Section Cancer Pathophysiology)
Show Figures

Figure 1

Figure 1
<p>Flowchart showing the methods for the selection of the studies included in this review. From [<a href="#B5-cancers-16-03747" class="html-bibr">5</a>].</p>
Full article ">Figure 2
<p>Histograms showing patient distributions for sex and age, main presenting symptoms and signs, anatomical origin of the lesion. Kaplan–Meier curve of the follow-up.</p>
Full article ">
Back to TopTop